![Kentaro Yoshimatsu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kentaro Yoshimatsu
Gründer bei Rin Institute, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Yasushi Okada | M | 65 | 43 Jahre | |
Sayoko Sasaki | F | 55 | 33 Jahre | |
Kenta Takahashi | M | 64 | 41 Jahre | |
Tatsuyuki Yasuno | M | 56 | 33 Jahre | |
Masatomi Akana | M | 57 | 34 Jahre | |
Lynn Kramer | M | 73 | 15 Jahre | |
Hiroyuki Kato | M | 66 | 42 Jahre | |
Yoshiteru Kato | M | 64 | 36 Jahre | |
Teruyuki Masaka | M | 46 | 23 Jahre | |
Terushige Iike | M | 60 | 38 Jahre | |
Ivan Cheung | M | 47 | 19 Jahre | |
Nobutake Morii | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Hiroko Kimura | M | - |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Yuji Yamada | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Takehiko Sawabe | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Masayoshi Miyanaga | M | 66 |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Takashi Owa | M | 61 | 33 Jahre | |
Makoto Ohori | M | - |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Gary Bryan Hendler | M | 57 | 14 Jahre | |
Shohei Kanazawa | M | 59 | 36 Jahre | |
Yasuhiro Matsumura | M | - |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Tetsuya Mishima | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Koji Hagimoto | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Japan | 66 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kentaro Yoshimatsu
- Persönliches Netzwerk